ARTICLE · 15 SEPTEMBER 2026
Seventeen states and the District of Columbia have filed an amicus brief in a landmark consumer protection lawsuit that challenges whether federal regulators can scrutinize professional medical guidelines as deceptive advertising. The case centers on transgender healthcare standards but could establish precedent affecting how clinical guidance is developed and disseminated across all medical specialties.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
